Sorrento to acquire antibody-drug conjugation technology

12:22 PM | November 14, 2013 | Deepti Ramesh

Sorrento Therapeutics (San Diego), a publicly traded, development-stage biopharmaceutical company, says it has entered into a definitive agreement to acquire Concortis Biosystems (San Diego) in a deal...